Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
abbvie
4
×
biotech
4
×
clinical trials
eli lilly
fda
life sciences
national blog main
national top stories
allergan
boston blog main
boston top stories
national
new york blog main
amgen
astrazeneca
avexis
boulder/denver blog main
boulder/denver top stories
bristol-myers squibb
celgene
detroit blog main
detroit top stories
europe blog main
genentech
indiana blog main
indiana top stories
johnson & johnson
merck
microbiome
new york top stories
pfizer
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
What
fda
4
×
treatment
approved
bio
drug
news
roundup
won
adults
alkermes
allergan
antipsychotic
august
benefits
biotech
busy
caveats
class
commonly
companies
days
decisions
designed
devices
digital
disease
drugs
effect
epidemic
fatty
favor
frenzied
gain
growing
known
led
legacy
liver
medicine
medicines
Language
unset
Current search:
abbvie
×
fda
×
biotech
×
@xconomy.com
3 years ago
FDA Panel Vote Weighs in Favor of Alkermes Psyche Drug, With Caveats
@xconomy.com
4 years ago
Allergan Wins FDA Nod for First Migraine Pill in New Class of Medicines
@xconomy.com
4 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More